USP19 Stabilizes TAK1 to Regulate High Glucose/Free Fatty Acid-induced Dysfunction in HK-2 Cells

Abstract

Objective

Obesity-induced kidney injury contributes to the development of diabetic nephropathy (DN). Here, we identified the functions of ubiquitin-specific peptidase 19 (USP19) in HK-2 cells exposed to a combination of high glucose (HG) and free fatty acid (FFA) and determined its association with TGF-beta-activated kinase 1 (TAK1).

Methods

HK-2 cells were exposed to a combination of HG and FFA. USP19 mRNA expression was detected by quantitative RT-PCR (qRT-PCR), and protein analysis was performed by immunoblotting (IB). Cell growth was assessed by Cell Counting Kit-8 (CCK-8) viability and 5-ethynyl-2′-deoxyuridine (EdU) proliferation assays. Cell cycle distribution and apoptosis were detected by flow cytometry. The USP19/TAK1 interaction and ubiquitinated TAK1 levels were assayed by coimmunoprecipitation (Co-IP) assays and IB.

Results

In HG+FFA-challenged HK-2 cells, USP19 was highly expressed. USP19 knockdown attenuated HG+FFA-triggered growth inhibition and apoptosis promotion in HK-2 cells. Moreover, USP19 knockdown alleviated HG+FFA-mediated PTEN-induced putative kinase 1 (PINK1)/Parkin pathway inactivation and increased mitochondrial reactive oxygen species (ROS) generation in HK-2 cells. Mechanistically, USP19 stabilized the TAK1 protein through deubiquitination. Importantly, increased TAK1 expression reversed the USP19 knockdown-mediated phenotypic changes and PINK1/Parkin pathway activation in HG+FFA-challenged HK-2 cells.

Conclusion

The findings revealed that USP19 plays a crucial role in promoting HK-2 cell dysfunction induced by combined stimulation with HG and FFAs by stabilizing TAK1, providing a potential therapeutic strategy for combating DN.

References

[1] GuptaS, DominguezM, GolestanehL. Diabetic Kidney Disease: An Update. Med Clin North Am, 2023, 107(4): 689-705

[2] DagarN, DasP, BishtP, et al.. Diabetic nephropathy: A twisted thread to unravel. Life Sci, 2021, 278: 119635

[3] YangM, ChenW, HeL, et al.. Intermittent Fasting-A Healthy Dietary Pattern for Diabetic Nephropathy. Nutrients, 2022, 14(19): 3995

[4] Opazo-RíosL, MasS, Marín-RoyoG, et al.. Lipotoxicity and Diabetic Nephropathy: Novel Mechanistic Insights and Therapeutic Opportunities. Int J Mol Sci, 2020, 21(7): 2632

[5] BaylissG, WeinrauchLA, D’EliaJA. Pathophysiology of obesity-related renal dysfunction contributes to diabetic nephropathy. Curr Diab Rep, 2012, 12(4): 440-446

[6] ChenSJ, LvLL, LiuBC, et al.. Crosstalk between tubular epithelial cells and glomerular endothelial cells in diabetic kidney disease. Cell Prolif, 2020, 53(3): e12763

[7] KitamuraH. Ubiquitin-Specific Proteases (USPs) and Metabolic Disorders. Int J Mol Sci, 2023, 24(4): 3219

[8] YouY, WangH, WangQ, et al.. Silencing USP19 alleviates cigarette smoke extract-induced mitochondrial dysfunction in BEAS-2B cells by targeting FUNDC1. Open Med (Wars), 2023, 18(1): 20230798

[9] ZhangX, ChenX, QianF, et al.. Deubiquitinase USP19 modulates apoptotic calcium release and endoplasmic reticulum stress by deubiquitinating BAG6 in triple negative breast cancer. Clin Transl Med, 2023, 13(9): e1398

[10] LeiCQ, WuX, ZhongX, et al.. USP19 Inhibits TNF-α- and IL-1β-Triggered NF-κB Activation by Deubiquitinating TAK1. J Immunol, 2019, 203(1): 259-268

[11] LiuT, WangL, LiangP, et al.. USP19 suppresses inflammation and promotes M2-like macrophage polarization by manipulating NLRP3 function via autophagy. Cell Mol Immunol, 2021, 18(10): 2431-2442

[12] TianZ, XuC, HeW, et al.. The deubiquitinating enzyme USP19 facilitates hepatocellular carcinoma progression through stabilizing YAP. Cancer Lett, 2023, 577: 216439

[13] ZhangJ, van DintherM, ThorikayM, et al.. Opposing USP19 splice variants in TGF-β signaling and TGF-β-induced epithelial-mesenchymal transition of breast cancer cells. Cell Mol Life Sci, 2023, 80(2): 43

[14] CoyneES, BedardN, WykesL, et al.. Knockout of USP19 Deubiquitinating Enzyme Prevents Muscle Wasting by Modulating Insulin and Glucocorticoid Signaling. Endocrinology, 2018, 159(8): 2966-2977

[15] CoyneES, BédardN, GongYJ, et al.. The deubiquitinating enzyme USP19 modulates adipogenesis and potentiates high-fat-diet-induced obesity and glucose intolerance in mice. Diabetologia, 2019, 62(1): 136-146

[16] ZhuY, GuL, LinX, et al.. USP19 exacerbates lipogenesis and colorectal carcinogenesis by stabilizing ME1. Cell Rep, 2021, 37(13): 110174

[17] MaM, DangY, ChangB, et al.. TAK1 is an essential kinase for STING trafficking. Mol Cell, 2023, 83(21): 3885-3903

[18] MihalySR, Ninomiya-TsujiJ, MoriokaS. TAK1 control of cell death. Cell Death Differ, 2014, 21(11): 1667-1676

[19] LanT, JiangS, ZhangJ, et al.. Breviscapine alleviates NASH by inhibiting TGF-β-activated kinase 1-dependent signaling. Hepatology, 2022, 76(1): 155-171

[20] CaoH, LuJ, DuJ, et al.. TAK1 inhibition prevents the development of autoimmune diabetes in NOD mice. Sci Rep, 2015, 5: 14593

[21] WangY, MaoY, ZhangX, et al.. TAK1 may promote the development of diabetic nephropathy by reducing the stability of SnoN protein. Life Sci, 2019, 228: 1-10

[22] WeiTT, YangLT, GuoF, et al.. Activation of GPR120 in podocytes ameliorates kidney fibrosis and inflammation in diabetic nephropathy. Acta Pharmacol Sin, 2021, 42(2): 252-263

[23] DograS, BandiS, ViswanathanP, et al.. Arsenic trioxide amplifies cisplatin toxicity in human tubular cells transformed by HPV-16 E6/E7 for further therapeutic directions in renal cell carcinoma. Cancer Lett, 2015, 356(2): 953-961 Pt B

[24] LittleAC, KovalenkoI, GooLE, et al.. High-content fluorescence imaging with the metabolic flux assay reveals insights into mitochondrial properties and functions. Commun Biol, 2020, 3(1): 271

[25] ZhangY, LiuP, WenD, et al.. Regulation of Cervical Cancer Development by a Novel Circ_0000212/miR-1236-3p/GREM1 ceRNA Crosstalk. Mol Biotechnol, 2023, 65(12): 2086-2098

[26] SilvianLF. PINK1/Parkin Pathway Activation for Mitochondrial Quality Control - Which Is the Best Molecular Target for Therapy?. Front Aging Neurosci, 2022, 14: 890823

[27] SherkhaneB, KalvalaAK, ArruriVK, et al.. Renoprotective potential of myo-inositol on diabetic kidney disease: Focus on the role of the PINK1/Parkin pathway and mitophagy receptors. J Biochem Mol Toxicol, 2022, 36(6): e23032

[28] CockramPE, KistM, PrakashS, et al.. Ubiquitination in the regulation of inflammatory cell death and cancer. Cell Death Differ, 2021, 28(2): 591-605

[29] LiH, WangY, SuX, et al.. San-Huang-Yi-Shen Capsule Ameliorates Diabetic Kidney Disease through Inducing PINK1/Parkin-Mediated Mitophagy and Inhibiting the Activation of NLRP3 Signaling Pathway. J Diabetes Res, 2022, 2022: 2640209

[30] ZhuY, GuL, LinX, et al.. P53 deficiency affects cholesterol esterification to exacerbate hepatocarcinogenesis. Hepatology, 2023, 77(5): 1499-1511

[31] WangY, ZhaoL, QiuD, et al.. Effects of transforming growth factor beta-activated kinase 1 (TAK1) on apoptosis of HK-2 cells in the high glucose environment. Bioengineered, 2022, 13(3): 5880-5891

[32] DengB, SongA, ZhangC. Cell-Cycle Dysregulation in the Pathogenesis of Diabetic Kidney Disease: An Update. Int J Mol Sci, 2023, 24(3): 2133